Rune Labs, Inc.
The last decade has seen amazing progress in neuroscience, enabling researchers to envision a new generation of brain machine interfaces. These systems will be used to treat chronic diseases like Parkinson's, epilepsy, and Alzheimer's. They will restore mobility to the paralyzed and speed recovery from a stroke. They may even allow us to control our mood and enhance our cognition. Rune Labs wants to build the software at the heart of these systems, and help accelerate the next wave of neuromodulation applications.www.runelabs.io
3
MENTIONS
1
EPISODES
1
PODCASTS
Search complete. 3 mentions across 1 episode found for "Rune Labs, Inc.".
Sep 25, 2026
Chris KustenbotterHOST
And the mission of this podcast is to help as many people as possible living with Parkinson's to lead a great quality of life.
Chris KustenbotterHOST
Now, today, I'm honored to have Amy Gordon-Friesen from RuneLabs with me today.
Chris KustenbotterHOST
And we're going to talk about Strive PD.
Chris KustenbotterHOST
And Strive PD is an app that I've been using for the past year.
Amy Gordon FranzenGUEST
But at Tempest, I learned that you can really chip away at those problems and improve quality of life and quality of care.
Amy Gordon FranzenGUEST
I did a 23andMe test yesterday.
Amy Gordon FranzenGUEST
15 years ago and the results showed that i have a lark 2 mutation that predisposes me and my genetic line to parkinson's and so this disease in particular has always been at the front of my mind in something that i care deeply about and care to learn more about and so after i kind of built my arsenal of tools at tempest it felt like a great opportunity for me to use what I learned there and bring it to RuneLabs, which today is very focused in neurodegenerative disease and specifically in Parkinson's.
Chris KustenbotterHOST
And what was the biggest surprise you had when you moved over in terms of going from oncology to Parkinson's? Was there something that you weren't aware of before that really made you think differently about Parkinson's?